InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
57,912.02
(
2.23%
)
Post# of 4764
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biophud

Send PM Follow Ignore
Followers 0
Posts 394
Boards Moderated 0
Alias Born 08/12/2006

biophud

Re: None

Thursday, 12/14/2006 12:42:57 PM

Thursday, December 14, 2006 12:42:57 PM

Post# of 4764
According to this report Avastin is a pill. A good example why you have to be critical when reading media reports about biotech/pharma drugs.

If reporters can't get this correct (Avastin is an antibody, not a pill) then how can we expect then to understand and report more complex and subtle biotech issue (IgG1 vs. IgG2 antibodies)?

Like this report on Avastin, the vast majority of media reports on IMCL are very superficial, and (IMHO) unfair to IMCL.

http://yahoo.reuters.com/news/articlehybrid.aspx?storyID=urn:newsml:reuters.com:20061214:MTFH97164_2...

biophud
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up